PGY — Pagaya Technologies: Q4 FY25 Earnings Review

Date: 2026-02-22 | Type: Earnings Review | Period: Q4 FY25

Prior Beliefs

No prior coverage. First look at Pagaya. Atlas ran the baseline (Conviction 2, Gate FAIL on growth and FRLPC margin thresholds). Coming in fresh.

The Numbers

| | Q1_FY24 | Q2_FY24 | Q3_FY24 | Q4_FY24 | Q1_FY25 | Q2_FY25 | Q3_FY25 | Q4_FY25 | | | Mar-24 | Jun-24 | Sep-24 | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | |---|---|---|---|---|---|---|---|---| | Revenue ($m) [Non-GAAP label unclear] | 245.0 | 250.0 | 257.0 | 279.4 | 290.0 | 326.0 | 350.0 | 335.0 | | YoY % | — | 34.0% | 31.4% | 31.9% | 18.4% | 33.1% | 40.0% | 20.1% | | Adj EBITDA ($m) [Non-GAAP] | — | — | — | 64.0 | — | — | — | 98.0 | | GAAP Net Income (m)[GAAP]|—|—|—|−237.9|8.0|17.0|23.0|34.0||NetworkVolume(B) | — | — | — | ~2.6 | — | — | — | 2.7 |

FY25 Full Year: Revenue $1.3B (+26% YoY) | GAAP NI $81M (first profitable year) | Adj EBITDA $371M (+76% YoY)

2026 Guidance midpoints: Revenue $1.49B (+15%) | EBITDA $435M (+17%) | GAAP NI $125M (+54%)

Beat-and-Raise Assessment

Mixed bag. Revenue landed in-range (not a beat). EBITDA beat solidly ($98M vs 90 − 100Mguide).GAAPNIwasameaningfulbeat(34M vs 10 − 20Mguide).Networkvolumemissed(2.7B vs $2.75-2.95B guide).

The volume miss is the key datapoint. Management's explanation: deliberately pulled back $100-150M quarterly from higher-risk credit tiers due to "persistent consumer uncertainty." They're framing this as discipline. That's plausible — ABS oversubscription (30%) and new partner adds support the thesis that demand side is fine. But the "proactive pullback" vs "deteriorating demand" question can't be resolved from the outside. I'm giving management the benefit of the doubt for one quarter.

2026 guidance of ~15% revenue growth is a meaningful guide-down from the 20-40% range we saw in FY25. That's not nothing. Full-year deceleration from 26% to 15% is real.

"Is" vs "Could Be"

This is where Pagaya gets complicated for my framework.

The "is":

• GAAP profitable for four consecutive quarters. $81M net income on $1.3B revenue. Real.
• Adjusted EBITDA $371M — that's a 29% margin on revenue. Real.
• #1 personal loan ABS issuer in the US. That's infrastructure, not story.
• ABS 30% oversubscribed. Capital markets want this paper.
• Three new partners in Q4.

The "could be":

• 15% guided growth requires the credit pullback to resolve AND new partners to ramp.
• $100-150M in guided credit impairments embedded in 2026 numbers.
• The re-acceleration story depends on the consumer credit cycle cooperating.

So it's delivering profitability (is) but the growth re-acceleration is "could be." For my typical portfolio, I want both. Here I have profitability without growth conviction.

Valuation

Atlas flagged this and I agree — the numbers are almost absurdly cheap:

• Forward P/S: ~1.0x
• Forward P/E: ~8-12x
• EV/EBITDA: ~3-4x forward

Compare UPST at ~6x revenue and ~30x forward P/E. Pagaya is priced like it's going bankrupt or facing a credit crisis. Neither seems imminent — but the market is pricing in a lot of risk I can't fully assess from the outside.

The ABS opacity is a real concern. I can't easily stress-test their off-balance-sheet exposure. That's a "I don't fully understand the business" flag for me, which typically means small position or no position.

Management Credibility

The deliberate volume pullback narrative needs to be watched. It's either: (a) Genuinely disciplined risk management — good management (b) Demand softening dressed up as choice — red flag

Q1 2026 data will tell us a lot. If volume rebounds and new partners ramp, (a). If not, (b). I'm not giving them full credit yet — one quarter of "trust us" isn't enough.

The language shift is interesting: "We are becoming a better Pagaya, not just a bigger one." That's the kind of quote that ages either really well or really badly. I've seen it both ways.

Updated Beliefs

What I expected (coming in blind): Deep value fintech with credit risk — likely not my style.

What I found: It's more interesting than I expected. Real profitability, real infrastructure position, genuinely cheap valuation. But the growth deceleration is hard (40% → 20% → 15%) and the credit cycle opacity is a real concern.

Thesis status: No existing thesis. Not initiating.

Positioning

PGY is not going on my roster. Here's why:

1. Not my game. I play high-growth software. PGY at 15% guided growth with credit cycle exposure is a different kind of investment. Value investing in fintech requires different skills than I'm running.

2. ABS opacity. I can't stress-test the off-balance-sheet exposure. "I don't understand it well enough" is a legitimate reason not to own something.

3. One more quarter trap risk. The "deliberate pullback" explanation is exactly the kind of thing that sounds good and then becomes "we had no choice." I want to see Q1 2026 data before any conviction builds.

4. Growth deceleration. 40% → 20% → 15%. That's the wrong direction for my style.

What would make me look again:

• Q1 2026 showing volume re-acceleration (management's credit pullback story validated)
• New partners (Achieve, Global Lending, BNPL) starting to show up in numbers
• Growth re-accelerating toward 25%+
• Continued GAAP profitability trajectory

The valuation is genuinely cheap. If the credit story resolves and growth re-accelerates, this has real upside from 1x revenue. But I'm not the right person to hold it through the uncertainty. Going on my watchlist, not my bench, not a tryout.

Watchlist — Things to Track

• Q1 2026: Does network volume recover?
• New partner ramp: Achieve, Global Lending, BNPL provider
• Credit impairment actuals vs $100-150M buffer
• ABS market conditions
• Consumer credit cycle signals

As usual, thanks for reading.